Stefan Beissert
Researcher Next ID · RN-032307
Researcher · Biochemistry, Genetics and Molecular Biology
University Hospital Carl Gustav Carus
Dresden, Germany
- Works count
- 1,234
- Citation count
- 11,452
- H-index
- 59
- i10-index
- 154
Research interests
Publications
Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Journal of Clinical Medicine · 2020 · 10.3390/jcm9010223
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
Journal of the European Academy of Dermatology and Venereology · 2020 · https://doi.org/10.1111/jdv.16752
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis
JAMA Dermatology · 2019 · 10.1001/jamadermatol.2019.3617
Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Journal of the American Academy of Dermatology · 2014 · 10.1016/j.jaad.2014.08.024
Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing
Cell Death and Disease · 2013 · 10.1038/cddis.2013.249
Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial
Journal of Investigative Dermatology · 2010 · 10.1038/jid.2010.91
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
Nature Medicine · 2010 · https://doi.org/10.1038/nm.2150
Endothelial basement membrane laminin α5 selectively inhibits T lymphocyte extravasation into the brain
Nature Medicine · 2009 · https://doi.org/10.1038/nm.1957
IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice
The Journal of Immunology · 2007 · 10.4049/jimmunol.179.1.365
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid
Archives of Dermatology · 2007 · https://doi.org/10.1001/archderm.143.12.1536
Spontaneous tumor rejection by cbl-b –deficient CD8+ T cells
The Journal of Experimental Medicine · 2007 · 10.1084/jem.20061699
Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse
Blood · 2007 · 10.1182/blood-2006-10-053793
Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation
Blood · 2006 · 10.1182/blood-2005-12-023044
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Nature Medicine · 2006 · https://doi.org/10.1038/nm1518
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus
Archives of Dermatology · 2006 · 10.1001/archderm.142.11.1447
Prevention of UV radiation–induced immunosuppression by IL-12 is dependent on DNA repair
The Journal of Experimental Medicine · 2005 · 10.1084/jem.20041212
Regulatory T Cells
Journal of Investigative Dermatology · 2005 · 10.1038/sj.jid.5700004
Frontline: Neuropilin‐1: a surface marker of regulatory T cells
European Journal of Immunology · 2004 · https://doi.org/10.1002/eji.200324799
Ultraviolet Radiation-Induced Regulatory T Cells Not Only Inhibit the Induction but Can Suppress the Effector Phase of Contact Hypersensitivity
The Journal of Immunology · 2004 · 10.4049/jimmunol.172.2.1036
Overexpression of Cd40 Ligand in Murine Epidermis Results in Chronic Skin Inflammation and Systemic Autoimmunity
The Journal of Experimental Medicine · 2001 · https://doi.org/10.1084/jem.194.5.615
Evidence for Functional Relevance of CTLA-4 in Ultraviolet-Radiation-Induced Tolerance
The Journal of Immunology · 2000 · 10.4049/jimmunol.165.4.1824
Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells
The Journal of Immunology · 2000 · 10.4049/jimmunol.165.5.2374
Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases
Journal of the American Academy of Dermatology · 1999 · https://doi.org/10.1016/s0190-9622(99)80048-6
Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
Immunology Today · 1995 · 10.1016/0167-5699(95)80125-1
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
The Journal of Immunology · 1995 · 10.4049/jimmunol.154.3.1280
Current projects
No projects listed.